Skip to main content
Joseph Ruggiero, MD, Oncology, New York, NY

Joseph T Ruggiero MD

Hematologic Oncology, Neuro-Oncology


Associate Professor, Medicine, Weill Cornell Medical College

Join to View Full Profile
  • 428 E 72nd StOfc 300New York, NY 10021

  • Phone+1 212-746-2083

  • Fax+1 212-746-3305

Dr. Ruggiero is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1983 - 1984
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1980 - 1983
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1977 - 1980
  • New York University School of Medicine
    New York University School of MedicineClass of 1977

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1978 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • America's Top Doctors for Cancer Castle Connolly, 2008-2013
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Harm Reduction: An Alternative Approach to Managing Addiction
    Harm Reduction: An Alternative Approach to Managing AddictionDecember 9th, 2020
  • Gastrointestinal Stromal Tumors Already Proving to Be Treatable with Targeted Therapies
    Gastrointestinal Stromal Tumors Already Proving to Be Treatable with Targeted TherapiesMarch 23rd, 2016

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: